NEW YORK, May 31, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The term in-vitro/in-vivo diagnostics (IV2D) describes the integration of molecular diagnostics with radiology and pathology (imaging), as well as new software and IT platforms. The aims of this integration are to improve patient care. This report provides an overview of current developments in integrated medical diagnostics, covering the emergence of new IV2D methods that combine IVD with current and developing imaging platforms. The drivers of this integration are reviewed including new disease biomarkers, single, combined and emerging imaging systems, as well as IT and patient-centred systems.
Scope of this research
• Assess the key technologies that will enable in vivo, in vitro diagnostic integration.
• Understand how IVD methods, biomarkers and imaging methods have been applied to challenges of diagnosis in breast cancer and Alzheimer's disease.
• Discover how centres of expertise, such as academic departments, are driving new discoveries and offering valuable alliances to diagnostic companies.
• Understand the factors that are driving healthcare providers to develop improved healthcare programmes through integration in medical diagnostics.
Research and anal